Cargando…
Efficacy and safety of alfacalcidol in Chinese postmenopausal women aged over 65 with osteoporosis or osteopenia: An open label, non-comparative, post marketing observational study
This study aimed to explore the therapeutic efficacy and safety of alfacalcidol among Chinese postmenopausal women (age >65 years) with osteoporosis or osteopenia. A total of 62 postmenopausal women with osteoporosis or osteopenia (>65 years) were recruited from urban residential community of...
Autores principales: | Li, Nan, Jiang, Yan, He, Shuli, Zhao, Zhen, Sun, Jing, Li, Mei, Wang, Ou, Xing, Xiaoping, Xia, Weibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393057/ https://www.ncbi.nlm.nih.gov/pubmed/30461612 http://dx.doi.org/10.1097/MD.0000000000013159 |
Ejemplares similares
-
The Gut Microbiome Is Altered in Postmenopausal Women With Osteoporosis and Osteopenia
por: Rettedal, Elizabeth A, et al.
Publicado: (2021) -
Discovery and Identification of Serum Succinyl‐Proteome for Postmenopausal Women with Osteoporosis and Osteopenia
por: Zhang, Li‐li, et al.
Publicado: (2019) -
Prevalence and Predictors of Osteoporosis and Osteopenia in Postmenopausal Women of Punjab, India
por: Khinda, Rubanpal, et al.
Publicado: (2022) -
Comparison of the Effects of Alendronate and Alfacalcidol on Hip Bone Mineral Density and Bone Turnover in Japanese Men Having Osteoporosis or Osteopenia with Clinical Risk Factors for Fractures
por: Iwamoto, Jun, et al.
Publicado: (2009) -
Comparative effect of eldecalcitol and alfacalcidol on bone microstructure: A preliminary report of secondary analysis of a prospective trial
por: Ni, Xiaolin, et al.
Publicado: (2021)